Expertenempfehlung: Therapie nichtgehfähiger Patienten mit Muskeldystrophie Duchenne

BACKGROUND: Duchenne muscular dystrophy (DMD) is the most frequent genetic neuromuscular disease in childhood with loss of ambulation usually occurring around the age of 9–11 years. OBJECTIVE, MATERIAL AND METHODS: Based on current guidelines and clinical trials, neuropediatric and neurological expe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernert, Guenther, Hahn, Andreas, Köhler, Cornelia, Meyer, Sascha, Schara, Ulrike, Schlachter, Kurt, Trollmann, Regina, Walter, Maggie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2020
Materias:
Übersichten
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026471/
https://www.ncbi.nlm.nih.gov/pubmed/33215271
http://dx.doi.org/10.1007/s00115-020-01019-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026471/
https://www.ncbi.nlm.nih.gov/pubmed/33215271
http://dx.doi.org/10.1007/s00115-020-01019-3

Ejemplares similares